Adtalem Global Education (NYSE:CVSA) CEO Sells 3,639 Shares of Company Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 3,639 shares of the firm’s stock in a transaction on Thursday, October 8th. The shares were sold at an average price of $130.37, for a total transaction of $474,416.43. Following the sale, the chief executive officer owned 473,825 shares in the company, valued at approximately $61,772,565.25. This represents a 0.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Shares of Adtalem Global Education stock traded down $1.02 during trading hours on Friday, reaching $129.27. The stock had a trading volume of 195,878 shares, compared to its average volume of 365,483. The stock’s 50 day moving average is $128.36 and its 200 day moving average is $123.69. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45. Adtalem Global Education Inc. has a twelve month low of $86.97 and a twelve month high of $156.26. The firm has a market capitalization of $4.38 billion, a PE ratio of 18.36, a PEG ratio of 0.94 and a beta of 0.65.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, August 6th. The company reported $2.09 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The firm had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Equities analysts expect that Adtalem Global Education Inc. will post 9 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CVSA. Truist Financial lowered Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price objective on the stock. in a report on Thursday, September 3rd. Weiss Ratings lowered Adtalem Global Education from a “hold (c+)” rating to a “hold (c)” rating in a research report on Tuesday. BMO Capital Markets dropped their price target on shares of Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating on the stock in a research note on Monday. Finally, Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Sunday, September 27th. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $151.67.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management acquired a new stake in Adtalem Global Education Inc. (NYSE:CVSA) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 11,622 shares of the company’s stock, valued at approximately $1,449,000. Institutional investors own 98.84% of the company’s stock.

About Adtalem Global Education

Adtalem Global Education is an education services company that provides professional, postsecondary and healthcare-focused education through institutions and brands serving students and working professionals. Its offerings include degree programs, career training, certification preparation and continuing education.

The company’s academic institutions include Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and the Medical University of the Americas.